The next age of immunotherapy: optimisation, stratification and therapeutic synergies

Cancer immunotherapy has entered a phase of broad application in the treatment of patients with haematologic and solid tumours. From first steps to standard of care, immunotherapy has established its utility and applicability across different cancer types. Now it must demonstrate its higher potentia...

Descripción completa

Detalles Bibliográficos
Autor principal: Halama, Niels
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2018
Materias:
Editorial
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6325151/
https://www.ncbi.nlm.nih.gov/pubmed/30413823
http://dx.doi.org/10.1038/s41416-018-0330-4
_version_ 1783386087244169216
author Halama, Niels
author_facet Halama, Niels
author_sort Halama, Niels
collection PubMed
description Cancer immunotherapy has entered a phase of broad application in the treatment of patients with haematologic and solid tumours. From first steps to standard of care, immunotherapy has established its utility and applicability across different cancer types. Now it must demonstrate its higher potential in more personalised and stratified approaches.
format Online
Article
Text
id pubmed-6325151
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-63251512019-06-21 The next age of immunotherapy: optimisation, stratification and therapeutic synergies Halama, Niels Br J Cancer Editorial Cancer immunotherapy has entered a phase of broad application in the treatment of patients with haematologic and solid tumours. From first steps to standard of care, immunotherapy has established its utility and applicability across different cancer types. Now it must demonstrate its higher potential in more personalised and stratified approaches. Nature Publishing Group UK 2018-11-09 2019-01-08 /pmc/articles/PMC6325151/ /pubmed/30413823 http://dx.doi.org/10.1038/s41416-018-0330-4 Text en © The Author(s) 2018 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Editorial
Halama, Niels
The next age of immunotherapy: optimisation, stratification and therapeutic synergies
title The next age of immunotherapy: optimisation, stratification and therapeutic synergies
title_full The next age of immunotherapy: optimisation, stratification and therapeutic synergies
title_fullStr The next age of immunotherapy: optimisation, stratification and therapeutic synergies
title_full_unstemmed The next age of immunotherapy: optimisation, stratification and therapeutic synergies
title_short The next age of immunotherapy: optimisation, stratification and therapeutic synergies
title_sort next age of immunotherapy: optimisation, stratification and therapeutic synergies
topic Editorial
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6325151/
https://www.ncbi.nlm.nih.gov/pubmed/30413823
http://dx.doi.org/10.1038/s41416-018-0330-4
work_keys_str_mv AT halamaniels thenextageofimmunotherapyoptimisationstratificationandtherapeuticsynergies
AT halamaniels nextageofimmunotherapyoptimisationstratificationandtherapeuticsynergies

Ejemplares similares